Jerome Bressi, Ph.D. is Chief Regulatory & Quality Officer at Fate Therapeutics, overseeing all aspects of regulatory, quality assurance and quality control functions related to clinical development; chemistry, manufacturing and controls; and future commercialization. Prior to joining Fate, Dr. Bressi was President of BioPharma Regulatory Solutions, LLC, a pharmaceutical regulatory affairs and quality consulting company, where he worked with Janssen Research and Development as a Dossier Development and Operations Lead for the TREMFYA (guselkumab) BLA, MAA, and NDS, as well as sBLA for TREMFYA One-Press patient-controlled injector. Dr. Bressi also held key regulatory positions at Hyperion Therapeutics and Mast Therapeutics and has more than 25 years of biotechnology and pharmaceutical industry experience in drug discovery and development within oncology, autoimmune, and inherited genetic disorder therapeutic arenas. Dr. Bressi received a B.S. from the Department of Chemistry from the University of California, San Diego and a Ph.D. from the Department of Chemistry at the University of Washington.
